AWARDBPA CALLOther than small business
BPA call 75F40120F19018SUNTIVA, LLC
Overview
Award facts
- Net obligations
- $2.44M
- $2,441,441of $2.44M potential value
- Outlays (paid to date)
- $1.95M
- $1.95M paid of $2.44M obligated$1,953,433
- Period of performance
- Sep 4, 2020 to Sep 9, 2024
- Ended
- Modifications
- 6
- Latest action Sep 27, 2026
- Contract type
- BPA call
- PIID 75F40120F19018
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
PROFESSIONAL LEADERSHIP DEVELOPMENT DEUX
Dates and value
- Award date
- Signed on Sep 4, 2020
- Potential end of performance
- Oct 27, 2026
- Current value
- $2,441,441Base and exercised options
- Potential value (if all options are exercised)
- $2,441,441
- Parent contract vehicle
- 75F40119A10003 (BPA, multiple award) — 55 orders recorded under it
Obligations by fiscal year of action
- FY2026: -$58,459 (de-obligation)
- FY2023: $591,298
- FY2022: $675,258
- FY2021: $740,328
- FY2020: $493,016
Total across 5 fiscal years: $2,441,441
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 27, 2026. View on USAspending · Recipient on SAM.gov
Recipient
NameSUNTIVA, LLC
LocationTYSONS, VA
UEIL61FBMJQ36A3
CAGE code34ZB1
Business sizeOther than small businessSize at award, per the contracting officer
Organization typePartnership
Parent companySUNTIVA LLC
Business types and certifications
Minority-ownedSelf-certified small disadvantaged businessFor-profit organizationLimited liability companyPartnership or LLP
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugs; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Falls Church, Fairfax County, Virginia 22043-2004
- Congressional district (place of performance)
- VA-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- R410SUPPORT- PROFESSIONAL: PROGRAM EVALUATION/REVIEW/DEVELOPMENT (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- No set-aside used
- Contract pricing
- Time and materialsY
- Offers received
- 1
Contract details
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 4, 2020Base obligation at award: $493,016
- Latest action
- Sep 27, 2026 — CloseoutModification P00006; obligation change -$58,459; administrative: no change in scope or value
- Latest substantive action
- Jan 17, 2023 — Option exercisedModification P00005; obligation change +$591,298
- Latest funding action
- Jan 27, 2021 — Funding onlyModification P00001; obligation change +$82,748; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Option exercised3
- Funding only1
- Closeout1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$58,459
- Latest action: change in base and all options
- -$58,459
Socio-economic and policy
- Inherently governmental functions
- Closely associated,critical functionsCL,CT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- BPA callA
- Parent vehicle type
- BPAE
- Parent vehicle: multiple or single award
- Multiple awardM
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 7
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2020/2020-0600-000
- 075-2021/2021-0600-000
- 075-X-0600-000
- Object classes
- 25.1: Advisory and assistance services
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression